Narrative Medicine: theory, clinical practice and education-a scoping review
I Palla, G Turchetti, S Polvani - BMC Health Services Research, 2024 - Springer
Abstract Background The origin of Narrative Medicine dates back to more than 20 years ago
at an international level. Narrative Medicine is not an alternative to evidence-based …
at an international level. Narrative Medicine is not an alternative to evidence-based …
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN …
R Talarico, S Aguilera, T Alexander… - Clinical and …, 2022 - sfera.unife.it
In order to address the main challenges related to the rare diseases (RDs) the European
Commission launched the European Reference Networks (ERNs), virtual networks involving …
Commission launched the European Reference Networks (ERNs), virtual networks involving …
Optimizing patient care: a systematic review of multidisciplinary approaches for SLE management
G Galoppini, A Marangoni, F Cirilli, F Ruffilli… - Journal of Clinical …, 2023 - mdpi.com
Systemic lupus erythematosus (SLE) is characterized by multisystemic clinical
manifestations ranging from a relatively mild involvement to potentially life-threatening …
manifestations ranging from a relatively mild involvement to potentially life-threatening …
Exploring patient's experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach
D Marinello, D Zucchi, I Palla, S Aguilera, I Galetti… - RMD open, 2022 - rmdopen.bmj.com
Objective The aim of this work is to explore patient'unmet needs of rare and complex
rheumatic tissue diseases (rCTDs) patients during pregnancy and its planning by means of …
rheumatic tissue diseases (rCTDs) patients during pregnancy and its planning by means of …
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide
M Mosca, IN Bruce, J Andersen, MF Ugarte-Gil… - …, 2024 - academic.oup.com
SLE presents significant challenges for patients and health-care professionals (HCPs), both
across Europe and worldwide. Improving health-care outcomes for patients with SLE …
across Europe and worldwide. Improving health-care outcomes for patients with SLE …
[HTML][HTML] Addressing Diagnostic Gaps and Priorities of the Global Rare Diseases Community: Recommendations from the IRDiRC Diagnostics Scientific Committee
DR Adams, CDM van Karnebeek, SB Agullo… - European Journal of …, 2024 - Elsevier
ABSTRACT The International Rare Diseases Research Consortium (IRDiRC) Diagnostic
Scientific Committee (DSC) is charged with discussion and contribution to progress on …
Scientific Committee (DSC) is charged with discussion and contribution to progress on …
Designing rare disease care pathways in the Republic of Ireland: a co-operative model
AJ Ward, D Murphy, R Marron, V McGrath… - Orphanet Journal of …, 2022 - Springer
Abstract Background Rare diseases (RDs) are often complex, serious, chronic and multi-
systemic conditions, associated with physical, sensory and intellectual disability. Patients …
systemic conditions, associated with physical, sensory and intellectual disability. Patients …
Patient care pathways for pregnancy in rare and complex rheumatic diseases: results from an international survey
C Tani, D Zucchi, E Bellis, MB Talabi, C Frise… - The Journal of …, 2023 - jrheum.org
Objective To map existing organizational care pathways in clinical centers of expertise that
care for pregnant women affected by rare and complex connective tissue diseases (rcCTDs) …
care for pregnant women affected by rare and complex connective tissue diseases (rcCTDs) …
HTA challenges for appraising rare disease interventions viewed through the lens of an institutional multidimensional value framework
M Wagner, MM Goetghebeur, I Ganache… - Expert Review of …, 2023 - Taylor & Francis
Introduction Evaluating rare disease interventions poses challenges for HTA agencies,
including uncertainties and ethical issues and tensions. INESSS has recently adopted a …
including uncertainties and ethical issues and tensions. INESSS has recently adopted a …
Improving patient pathways for systemic lupus erythematosus: a multistakeholder pathway optimisation study
A Schlencker, L Messer, M Ardizzone… - Lupus science & …, 2022 - lupus.bmj.com
Objective Among the most significant challenges in SLE are the excessive diagnosis delay
and the lack of coordinated care. The aim of the study was to investigate patient pathways in …
and the lack of coordinated care. The aim of the study was to investigate patient pathways in …